November 15, 2018 - Page 24 of 28

NYSE Companies - November 15, 2018

Brady Corporation Reports Fiscal 2019 First Quarter Results and Increases its Fiscal 2019 EPS Guidance

Organic revenues increased 4.7 percent in the first quarter of fiscal 2019. Earnings before income taxes increased 14.8 percent to […]

NASDAQ Companies - November 15, 2018

Akers Biosciences Announces Q3 2018 Earnings

Sales of Flagship PIFA Heparin PF/4 Rapid Assay Products Up 16% over Q3 2017; Company Continuing to Evaluate Strategic Alternatives […]

NASDAQ Companies - November 15, 2018

Priority Review Granted to BeiGene’s New Drug Applications for Zanubrutinib and Tislelizumab in China

CAMBRIDGE, Mass., and BEIJING, China, Nov. 15, 2018 (GLOBE NEWSWIRE) — BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical […]

NASDAQ Companies - November 15, 2018

Bio-Path Holdings Reports Third Quarter 2018 Financial Results

Conference Call to be Held Today at 8:30 A.M. ET HOUSTON, Nov. 15, 2018 (GLOBE NEWSWIRE) — Bio-Path Holdings, Inc., […]

NASDAQ Companies - November 15, 2018

uniQure Announces Initial Topline Data from Dose-Confirmation Study of AMT-061 in Patients with Hemophilia B

~ All Patients Achieved and Sustained Therapeutic Factor IX Activity with a Mean FIX Level of 31% of Normal at […]

NASDAQ Companies - November 15, 2018

i3 Verticals Announces Earnings Release and Conference Call Dates for the Fourth Quarter of Fiscal 2018

NASHVILLE, Tenn., Nov. 15, 2018 (GLOBE NEWSWIRE) — i3 Verticals, Inc. (Nasdaq: IIIV) (“i3 Verticals” or the “Company”), announced today […]

NASDAQ Companies - November 15, 2018

Constellation Pharmaceuticals Highlights EZH2 Inhibition Program in Prostate Cancer at Biomedical Conference

CAMBRIDGE, Mass., Nov. 15, 2018 (GLOBE NEWSWIRE) — Constellation Pharmaceuticals, Inc., (Nasdaq: CNST) a clinical-stage biopharmaceutical company using its expertise in […]